The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...

Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

You've heard massaging it can relieve stress—now experts have found the 27 million U.S. autoimmune sufferers could find therapy here, too.

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.

Patients with rheumatoid arthritis are associated with an increased risk for heart failure, particularly heart failure with preserved ejection fraction.

Mass General Brigham researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery ...

As a child, I'd cry out at night due to the pains in my knees, my hips, my elbows, and my wrists, and the pediatrician made ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Women with an age at first birth younger than 26 or older than 35 years have a higher risk for developing rheumatoid arthritis later in life.

A recent study finds that genetically predicted rheumatoid arthritis is causally associated with prostate cancer.

Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating ...

The new treatment targets inflammation directly within the joints so that therapeutic agents are released only when needed.